Record Information |
---|
Version | 2.0 |
---|
Created at | 2020-11-23 19:43:37 UTC |
---|
Updated at | 2021-08-12 19:52:31 UTC |
---|
NP-MRD ID | NP0002919 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | cacodylic acid |
---|
Provided By | BMRB |
---|
Description | Dimethylarsinic acid, also known as dimethylarsinate or [as(CH3)2O(OH)], belongs to the class of organic compounds known as pentaorganoarsanes. These are organoarsenic compounds containing an arsenic compound that is pentasubstituted by only organic groups. In humans, dimethylarsinic acid is involved in the arsenate detoxification pathway. Dimethylarsinic acid is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Dimethylarsinic acid is formally rated as a possible carcinogen (by IARC 2B) and is also a potentially toxic compound. cacodylic acid was first documented in 2001 (PMID: 11379771). Based on a literature review a small amount of articles have been published on Dimethylarsinic acid (PMID: 21342701) (PMID: 11549254) (PMID: 21457993). |
---|
Structure | InChI=1S/C2H7AsO2/c1-3(2,4)5/h1-2H3,(H,4,5) |
---|
Synonyms | Value | Source |
---|
[As(CH3)2O(OH)] | ChEBI | CACODYLIC ACID | ChEBI | Dimethylarsinate | ChEBI | Kakodylsaeure | ChEBI | Me2as(=o)OH | ChEBI | CACODYLate | Generator | Dimethylarsinic acid | Generator | Acid, dimethylarsinic | MeSH, HMDB | Acid, cacodylic | MeSH, HMDB | As,As-Dimethylarsinic acid | HMDB | Dimethylarsenic acid | HMDB | Hydroxydimethylarsine oxide | HMDB |
|
---|
Chemical Formula | C2H7AsO2 |
---|
Average Mass | 137.9974 Da |
---|
Monoisotopic Mass | 137.96620 Da |
---|
IUPAC Name | dimethylarsinic acid |
---|
Traditional Name | ansar |
---|
CAS Registry Number | Not Available |
---|
SMILES | C[As](C)(O)=O |
---|
InChI Identifier | InChI=1S/C2H7AsO2/c1-3(2,4)5/h1-2H3,(H,4,5) |
---|
InChI Key | OGGXGZAMXPVRFZ-UHFFFAOYSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Not Available |
---|
Species Where Detected | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as pentaorganoarsanes. These are organoarsenic compounds containing an arsenic compound that is pentasubstituted by only organic groups. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organometallic compounds |
---|
Class | Organometalloid compounds |
---|
Sub Class | Organoarsenic compounds |
---|
Direct Parent | Pentaorganoarsanes |
---|
Alternative Parents | |
---|
Substituents | - Pentaorganoarsane
- Alkylarsine oxide
- Oxygen-containing organoarsenic compound
- Organic metalloid salt
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organic salt
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Yamanaka K, Mizol M, Kato K, Hasegawa A, Nakano M, Okada S: Oral administration of dimethylarsinic acid, a main metabolite of inorganic arsenic, in mice promotes skin tumorigenesis initiated by dimethylbenz(a)anthracene with or without ultraviolet B as a promoter. Biol Pharm Bull. 2001 May;24(5):510-4. doi: 10.1248/bpb.24.510. [PubMed:11379771 ]
- Maki T, Hirota W, Motojima H, Hasegawa H, Rahman MA: Influence of aggregated particles on biodegradation activities for dimethylarsinic acid (DMA) in Lake Kahokugata. Chemosphere. 2011 Jun;83(11):1486-92. doi: 10.1016/j.chemosphere.2011.01.059. Epub 2011 Feb 20. [PubMed:21342701 ]
- Yamanaka K, Takabayashi F, Mizoi M, An Y, Hasegawa A, Okada S: Oral exposure of dimethylarsinic acid, a main metabolite of inorganic arsenics, in mice leads to an increase in 8-Oxo-2'-deoxyguanosine level, specifically in the target organs for arsenic carcinogenesis. Biochem Biophys Res Commun. 2001 Sep 14;287(1):66-70. doi: 10.1006/bbrc.2001.5551. [PubMed:11549254 ]
- Mitchell W, Goldberg S, Al-Abadleh HA: In situ ATR-FTIR and surface complexation modeling studies on the adsorption of dimethylarsinic acid and p-arsanilic acid on iron-(oxyhydr)oxides. J Colloid Interface Sci. 2011 Jun 15;358(2):534-40. doi: 10.1016/j.jcis.2011.02.040. Epub 2011 Feb 24. [PubMed:21457993 ]
|
---|